跳轉至內容
Merck
全部照片(2)

文件

R9644

Sigma-Aldrich

利巴韦林

antiviral

同義詞:

1-β-D-呋喃核糖基-1,2,4-三唑-3-甲酰胺

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C8H12N4O5
CAS號碼:
分子量::
244.20
MDL號碼:
分類程式碼代碼:
12352202
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (TLC)

形狀

powder

溶解度

water: 19.60-20.40 mg/mL, clear, colorless to faintly yellow

抗生素活性譜

viruses

作用方式

DNA synthesis | interferes

儲存溫度

2-8°C

SMILES 字串

NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O

InChI

1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1

InChI 密鑰

IWUCXVSUMQZMFG-AFCXAGJDSA-N

基因資訊

尋找類似的產品? 前往 產品比較指南

一般說明

化学结构:核苷
嘌呤核苷酸生物合成中咪唑核苷酸中间体的类似物。

生化/生理作用

用于抵御多种人类病毒感染的抗病毒剂,特别是慢性肝炎C、HIV 和腺病毒。其代谢产物利巴韦林 5′-磷酸,是肌苷一磷酸 (IMP) 脱氢酶的抑制剂,但也有实验证据支持许多其他作用机制。
抗病毒剂。其代谢产物利巴韦林 5′-磷酸,是肌苷一磷酸 (IMP) 脱氢酶的抑制剂。用于抑制嘌呤(GTP 池)在肌苷单磷酸 (IMP) 脱氢酶级别的生物合成,并作为抑制病毒RNA依赖性RNA聚合酶的二磷酸和三磷酸的前体。

象形圖

Health hazard

訊號詞

Danger

危險聲明

危險分類

Muta. 2 - Repr. 1B

儲存類別代碼

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Chen-Hua Liu et al.
Annals of internal medicine, 159(11), 729-738 (2013-12-04)
Data are limited on the efficacy and safety of pegylated interferon plus ribavirin for patients with hepatitis C virus genotype 1 (HCV-1) receiving hemodialysis. To compare the efficacy and safety of combination therapy with pegylated interferon plus low-dose ribavirin and
Fred Poordad et al.
The New England journal of medicine, 370(21), 1973-1982 (2014-04-15)
Interferon-containing regimens for the treatment of hepatitis C virus (HCV) infection are associated with increased toxic effects in patients who also have cirrhosis. We evaluated the interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r), the NS5A inhibitor ombitasvir
M Colombo et al.
Gut, 63(7), 1150-1158 (2013-11-10)
Severe adverse events (AEs) compromise the outcome of direct antiviral agent-based treatment in patients with advanced liver fibrosis due to HCV infection. HEP3002 is an ongoing multinational programme to evaluate safety and efficacy of telaprevir (TVR) plus pegylated-interferon-α (PEG-IFNα) and
Marie Pellerin et al.
Viruses, 13(3) (2021-04-04)
Hepatitis E virus (HEV) is considered as an emerging global health problem. In most cases, hepatitis E is a self-limiting disease and the virus is cleared spontaneously without the need of antiviral therapy. However, immunocompromised individuals can develop chronic infection
Tao Meng et al.
Journal of virology, 88(10), 5803-5815 (2014-03-14)
In a screen for ribavirin resistance, a novel high-fidelity variant of human enterovirus 71 (EV71) with the single amino acid change L123F in its RNA-dependent RNA polymerase (RdRp or 3D) was identified. Based on the crystal structure of EV71 RdRp

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務